04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS See more
11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE See more
09/2021 W. L. Gore & Associates enhances GORE® VIABAHN® Endoprosthesis portfolio with lower profile delivery Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers See more
04/2025 W. L. GORE & ASSOCIATES LAUNCHES GORE® SYNECOR PREPERITONEAL BIOMATERIAL IN EUROPE, THE MIDDLE EAST AND SOUTH AFRICA See more